# OnCo record satricabtagene-autoleucel (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/satricabtagene-autoleucel/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "satricabtagene-autoleucel" ;
  schema:name "Satricabtagene autoleucel"@en ;
  schema:description "Satricabtagene autoleucel (satri-cel) is the first CAR-T therapy approved for a solid tumour (gastric cancer), in China."@en ;
  schema:url <https://onco.cc/drugs/satricabtagene-autoleucel/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(25)00860-8> ;
  onco:status "approved" ;
  onco:modality "CAR-T (Claudin 18.2)" ;
  onco:approval "China 2025: CLDN18.2+ advanced gastric/GEJ adenocarcinoma, previously treated" ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cldn18-2/> ;
  onco:companies <https://onco.cc/companies/carsgen/> ;
  onco:trials <https://onco.cc/trials/nct04581473/> .